Skip to main content

McKesson Corporation Q2 FY2027 results

  • MCK · NYSE
  • Distribution
  • Health Care Distributors
  • S&P 500
$1102.80+2.39%Close 13 Nov 2026 · Market value $127.9B

McKesson Corporation reported revenue of $111.0 billion, up 7.6% from a year earlier, net income of $1.22 billion and diluted earnings per share of $10.44 against $8.92 for the second quarter of fiscal 2027 (the three months to 30 Sep 2026).

From its quarterly report, filed 4 Nov 2026. Compiled and checked by AapWire.

Q2 FY2027 against Q2 FY2026

Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.

McKesson Corporation Q2 FY2027 results against the year-ago quarter
MeasureQ2 FY2027Q2 FY2026Change
Revenue$111.0B$103.2B+7.6%
Gross profit$3.96B$3.54B+11.7%
Gross margin3.6%3.4%+0.1 pts
Operating income$1.60B$1.41B+14.0%
Operating margin1.4%1.4%+0.1 pts
Net income$1.22B$1.11B+9.7%
Diluted EPS$10.44$8.92+17.0%
Operating cash flow$3.07B$2.42B+26.9%
Capital expenditure$65.00M$106.0M−38.7%
Free cash flow$3.00B$2.31B+29.9%

Operating KPIs for the quarter

McKesson Corporation operating KPIs, Q2 FY2027
KPIQ2 FY2027Change on a year
North American Pharmaceutical revenue$91.4Bup 5.6%
Oncology & Multispecialty revenue$15.0Bup 24.4%
Medical-Surgical Solutions revenue$3.1Bup 5.1%
Prescription Technology Solutions revenue$1.5Bup 10.5%

Earlier quarters

McKesson Corporation results, last eight filed quarters
QuarterPeriod endRevenueChange on a yearDiluted EPS
Q2 FY202730 Sep 2026$111.0B+7.6%$10.44
Q1 FY202730 Jun 2026$105.4B+7.7%$5.15
Q4 FY202631 Mar 2026$96.30B+6.0%$13.69
Q3 FY202631 Dec 2025$106.2B+11.4%$9.59
Q2 FY202630 Sep 2025$103.2B+10.1%$8.92
Q1 FY202630 Jun 2025$97.83B+23.4%$6.25
Q4 FY202531 Mar 2025$90.82B+18.9%$10.00
Q3 FY202531 Dec 2024$95.29B+17.8%$6.95

More on McKesson Corporation: financial statements · revenue · earnings per share

MCK's results, as they are filed.

Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.